±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 128  |  »Ø¸´: 0
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

glzeng

°æÖ÷

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

[½»Á÷] ÇóÖú£ºÉúÎï»îÐԲⶨ£¨10½ð±Ò£©½éÉÜÒ»ÏÂÄÄÀï¿ÉÒÔ×öÕâ¸öʵÑé

ÕâÊÇÔÚһƬרÀûÉÏ¿´µ½µÄ£¬ÎÒ°ÑËü·­ÒëÁËһϣ¬ÆäʵÎÒ×Ô¼ºÒ²²»ÍêÈ«¿´µÃ¶®£¬ÎÒ²»ÊÇ×öÉúÎï·½Ãæ£¬ËùÒÔ°ÝÍÐһϸ÷룬¿´Äܲ»ÄܽéÉÜÒ»ÏÂÕâ¸öʵÑéÔÚÄÄÀï¿ÉÒÔ×ö£¡

ʵÑéÄ¿µÄ£º ²â¶¨GA RSÏà¶Ô GA DSµÄÏà¶ÔÉúÎï»îÐÔ
ʵÑé·½°¸£º
ÃâÒß
ÖÆ±¸GA RSÈÜÒº
׼ȷ³ÆÈ¡15mg GA£¬ ÈܽâÔÚÎÞ¾úPBSÖÐÖÆ±¸5mg/mlµÄÈÜÒº
ÖÆ±¸GA RSÈé×´Òº
µÈÌå»ýGA RSÈÜÒº(5mg/ml)ºÍCFA»ìºÏ£¬»ìºÏÎï×ªÒÆÖÁÎÞ¾ú²£Á§×¢ÉäÆ÷£¬×¢ÉäÆ÷ͨ¹ýLuer bridgeÓëÁíÍâÒ»Ö»²£Á§×¢ÉäÆ÷ÏàÁ¬¡£Í¨¹ýÔÚÁ½Ö»×¢ÉäÆ÷Ö®¼äµÄÏà»¥×ªÒÆ¶øÊ¹Æä³ä·ÖÈ黯¡£Îȶ¨Èé×´ÒºµÄ¶¨ÒåÊÇÔÚË®ÃæÉÏÈé×´Òº²»·ÖÉ¢¡£
×¢É䣺
½«GA RSÈé×´Òº×ªÒÆÖÁÒȵºËØ×¢ÉäÆ÷£¬½«100µL GA RSÈé״ҺעÉ䵽С°×ÊóµÄËÄÖ»½ÅÕÆ(footpads)ÉÏ(ÿֻԼ25µL), ÃâÒßµÄС°×ÊóÓÃÓÚÌåÍâʵÑ飨9-11Ì죩
ÖÆ±¸³õ¼¶ÅàÑøµÄLNϸ°û
³õ¼¶ÅàÑøµÄLNϸ°ûµÄÈ¡×ÔÃâÒß9-11ÌìµÄС°×Êó¡£ÊÖÊõ֮ǰÔÚ¾»»¯ÕÖ/¹ñÖн«×ÏÍâµÆ´ò¿ª20min£¬ÊÖÊõ¿ªÊ¼Ê±¹Ø±Õ¡£ÔÚ½«ÊÔ¼Á·ÅÈë¾»»¯ÕÖ֮ǰÓÃ70£¥ÒÒ´¼ÈÜÒºÇå½à¹¤×÷Ì¨Ãæ¡£ ÖÆ±¸Enriched DCCM1 medium£¬Enriched DCCM1 mediumºÍRPMI mediumÔÚʹÓÃǰԤÈÈÖÁ37¡æ£¬½«Ð¡°×ÊóɱËÀºó£¨Å¤¶Ï²±×Ó£©¹Ì¶¨ÔÚÖ§³Åƽ̨ÉÏ£¬±³²¿×ŵء£¸¹²¿ÓÃ70£¥ÒÒ´¼Ïû¶¾ºóÇпªÒ»¸öÖеȴóСµÄ¿Ú×Ó£¬£¨Çпڳ¤¶Èͨ³£Îª2 cm£©£¬½«LN×ªÒÆÖÁº¬ÓÐÔ¼5mlÎÞ¾úRPMI mediumµÄÎÞ¾úÅàÑøÃóÖУ¬LNϸ°ûÐü¸¡ÒºÓÃÎÞ¾ú×¢ÉäÆ÷´ÓÅàÑøÃó×ªÒÆÖÁ50ml ÎÞ¾úÊԹܡ£
ϸ°û¼ÆÊý£º
×°ÓÐϸ°ûÐü¸¡ÒºµÄÎÞ¾úÊÔ¹ÜÖмÓÈëRPMI mediumÖÁ40ml£¬LNϸ°ûÔÚÊÒÎÂÏÂÀëÐÄ·ÖÀ루200¡Ág£©10min£¬¹ÌÌåÖØÐ·ÖÉ¢ÔÚ40mlRPMIÖУ¬Two aliquots of 50µL were drawn each from the cells¡¯ suspension diluted 4-fold with 150µL of 0.1% Trypan blue£¨×¶³æÀ¶£© in a microtest well. The aliquots were mixed wel by pipetting gently up and down¡£ÓøDz£Æ¬¸²¸ÇѪÇò¼Æ£¬½«Á½¸öaliquotÓÃ50£­200µLµÄÒÆÒº¹ÜÒÆÈëѪÇò¼ÆµÄÉÏÏÂÁ½¸öchamberÖУ¬»ìºÏÎϸ°ûÐü×ÇÒººÍ×¶³æÀ¶£©¿ÉÔÚchamberÖзÅÖÃÁ½·ÖÖÓ£¬²¢¿ÉÒÔ¸²¸ÇÕû¸öchamberµÄ±íÃæ£¬Èç¹ûchamberÖгöÏÖÆøÅÝ»òÕß¹ýÁ¿ÔòÐ轫ѪÇò¼ÆÍêÈ«ÇåÀí¸É¾»²¢¸ÉÔïºóÖØÐÂÉÏÑù¡£»îµÄϸ°û²»ÄÜÓë×¶³æÀ¶½áºÏ¶ø³ÊÏÖÎÞɫ״̬£¬ËÀϸ°ûÔòÓë×¶³æÀ¶½áºÏ¶øÏÔÀ¶É«¡£¼ÆËãϸ°û¼ÆÊý°åÖÐÑë·½¸ñÖеĻîϸ°ûÊýÄ¿£¬·½¸ñÖбßÔµµÄϸ°ûÖ»Óе±Ï¸°ûÈ«²¿ÔÚ·½¸ñÖвżÆÊý£¬Ï¸°ûÃܶÈͨ¹ýÏÂÃæµÄ¹«Ê½¼ÆË㣺
Average number viable cells(both chambles) ¡Á4¡Á104£½cells/ml
½«LNϸ°ûÔÚÊÒÎÂÏÂÀëÐÄ·ÖÀ루200¡Ág£©10min£¬¹ÌÌå·ÖÉ¢ÔÚenriched DCCM1ÖÐ,ÐγÉÃܶÈΪ1¡Á107 cells/mlµÄÈÜÒº¡£

ÌåÍâÉúÎï²â¶¨
ÌåÍâÉúÎï²â¶¨ÔÚFlat-bottomed ϸ°ûÅàÑø²âÊÔ°åÉϽøÐУ¬×îÖÕÌå»ýΪ1ml
ÖÆ±¸GA RSУÕýÇúÏß
Ò»¸öaliquotµÄ1 mg/ml GARSÓÃenriched DCCM1 mediumÏ¡ÊÍÖÁ100 µg/ml(10±¶)£¬ÓÃ0.2 µ
´×ËáÏËÎ¬ËØ¹ýÂË£¬ÖƱ¸6¸öŨ¶ÈΪ2-50 µg/mlµÄenriched DCCM1 mediumºÍGA RSÈÜÒº¡£


ÖÆ±¸Ï¡Å¨¶ÈGA DSÈÜÒº
׼ȷ³ÆÈ¡10-20 mg GA DSÈܽâÔÚddH2OÖÐÖÆ±¸1.2 mg/mlµÄÈÜÒº£¬¹âѧÃܶȣ¨OD£©ÔÚ275 nm´¦²â¶¨¡£ODÖµµ÷ÖÁ1.03£¬ÖƱ¸1 mg/mlÈÜÒº£¬È»ºóÓÃDCCM1Åä³É100 µg/mlÈÜÒº£¬ÓÃ0.2µ´×ËáÏËÎ¬ËØ¹ýÂË£¬¸ÃÈÜҺϡÊÍÖÁ10ºÍ20 µg/ml£¬ÈçÉÏ±í¡£

²â¶¨·´Ó¦£º
ÏÂÃæÕâЩÈÜÒº¼ÓÈëµ½24¸ñϸ°ûÅàÑø²âÊÔ°å

GA RS
0.5 ml LNϸ°û£¨×îºóÃܶÈÈ磺5¡Á106 cells/well£©£¬Ã¿¸öGA RSÏ¡ÊÍÒº0.5 ml£¬ÔÚ¸ñÖеÄ×îºóŨ¶ÈΪ£º25£¬15£¬10£¬5£¬2.5£¬1 µg/ml¡£
GA DSÑùÆ·
0.5 ml LNϸ°û£¨×îºóÃܶÈÈ磺5¡Á106 cells/well£©£¬Ã¿¸öGA DSÏ¡ÊÍÒº0.5 ml£¬ÔÚ¸ñÖеÄ×îºóŨ¶ÈΪ£º5£¬10 µg/ml¡£
ÿ¸ö²âÊÔ¶¼°üº¬ÈçÏ¿ØÖÆ£º
1£©        ¸º¿ØÖÆ£­ ÓÿØÖÆëÄÅàÑøLNϸ°û
   0.5 ml LNϸ°û£¨×îºóÃܶȣº5¡Á106 cells/well£©
   0.5 ml MBPëÄÈÜÒº£¨20 µg/ml£©ÓÃDCCM1Ï¡ÊÍ£¨×îºóŨ¶ÈΪ10 µg/ml£©
2£©Õý¿ØÖÆ£­ÓÃCon A£¨·ÇÌØÒìÐÔTϸ°û´Ì¼¤¼Á£©´Ì¼¤LNϸ°û
   0.5 ml LNϸ°û£¨×îºóÃܶȣº5¡Á106 cells/well£©
   0.5 ml Con A£¨5 µg/ml£©ÓÃDCCM1Ï¡ÊÍ£¨×îºóŨ¶ÈΪ2.5 µg/ml£©
ϸ°ûÃܶÈËæ×ÅËûÃǶÔGAµÄ·´Ó¦¶ø·¢Éú±ä»¯¡£ÅàÑøÌõ¼þΪ37 ¡æ£¬Êª¶È5£¥CO2±£ÎÂÏäÖÐ18-21 h£¬²âÊÔ°åÔÚÊÒÎÂÏÂÀëÐÄ10 min£¨200¡Ág£©£¬ÉÏÇåÒº×ªÒÆÖÁµÍιÜÖУ¬ÔÚ£­20¡æÏ¿ɱ£´æÒ»ÐÇÆÚ¡£

øÁªÃâÒßÎü¸½²â¶¨£¨ELISA£©°×½éËØ-2¼ì²â
ËùÓÐÑùÆ·²â¶¨´ÎÊýΪÈý´Î£¬Ã¿¸öplate¶¼°üº¬ÒÔÏ£º
1£©        °×½éËØ-2±ê×¼ÇúÏߣ­°üº¬ÖÁÉÙ6¸ö·ÇÁãŨ¶È°×½éËØ-2      
2£©        ¿Õ°×£«µÚÒ»¸ö¿¹Ì壬ûÓа׽éËØ-2 standard£¬£«µÚ¶þ¸ö¿¹Ì壨Áãµã£©
3£©        GA RSÅàÑøÃ½½é,²âÊÔÑùÆ·ÓÃDCCM1Ï¡ÊÍ£¬·½·¨ÈçÏÂ
a)        1, 2.5 µg/mlGA RS ÑùÆ·ÒÔ¼°·´¿ØÖÆÑùÆ·Ï¡ÊÍ2±¶
b)        5-25 µg/ml GA RS ÑùÆ·ºÍ²âÊÔÑùÆ·Ï¡ÊÍ5-10±¶
c)        Õý¿ØÖÆÑùÆ·(Con A)Ï¡ÊÍ15-20±¶
²â¶¨°×½éËØ-2ˮƽµÄELISA·½°¸°´ÕÕÖÆÔìÉÌÌṩµÄ·½·¨½øÐУ¬Èç¹û´ý²âÑùÆ·µÄODÖµ³¬¹ý»òµÍÓÚPlate readerµÄ¼«ÏÞÖµ£¬ÔòÑùÆ·ÐèÖØÐÂÅäÖúó½øÐзÖÎö¡£

¼ÆËãºÍ¿É½ÓÊܱê×¼

øÁªÃâÒßÎü¸½²â¶¨

ʵÀý2
ʵÑé2A£ºGA RS ÌØÒìÐÔTϸ°û·ÖÃÚµÄϸ°ûÒò×Ó
ÓÃ250 µg/mlGA RS/CFA¶Ô´ÆÐÔF1ÀÏÊóÃâÒß9-11Ì죬½«LNϸ°ûÌáÈ¡³öÀ´ºóÓò»Í¬Å¨¶ÈGA RSÅàÑø18-24 h£¬ÅàÑøÌõ¼þΪΪ37 ¡æ£¬Êª¶È5£¥CO2±£ÎÂÏäÖС£½ÓÏÂÀ´È¡ÆäÀëÐÄÉÏÇåÒºÓÃÓÚϸ°ûÒò×Ӳⶨ¡£
ÓöÔϸ°ûÒò×ÓºÍÁ´Ã¹¿¹ÉúËØµ°°×£­ËØÀ±¸ù¹ýÑõ»¯Îïø¾ßÓÐÌØÒìÐÔµÄÉúÎïËØ»¯¿¹Ìå½øÐÐøÁªÃâÒßÎü¸½²â¶¨¡£Ã¿¸öplate°üÀ¨¿Õ°×¿ØÖÆ£¨µÚÒ»¸öºÍµÚ¶þ¸ö¿¹Ìå²»º¬Ï¸°ûÒò×Ó±ê׼Ʒ£©£¬ÖÊÁ¿¿ØÖÆ£¨QC£©ÑùÆ·£¨Èý¸öŨ¶ÈÔÚ²âÊÔÏßÐÔ·¶Î§ÄÚµÄϸ°ûÒò×Ó±ê׼Ʒ£©¡£Ã¿¸öÌåÍâ²âÊÔ°üº¬Ò»¸öÕý¿ØÖÆ£¨Con A£¬·ÇÌØÒìÐÔTϸ°û´Ì¼¤¼Á£©ºÍÒ»¸ö¸º¿ØÖÆ£¨²»º¬GA»òÆäËû¿¹Ô­£©£¬ËùÓÐϸ°ûÒò×ӵIJâÊÔ¶¼ÔÚÅàÑø18-24 hÒÔºó¡£TGF-¦Â,IL-10ºÍIL-4ˮƽÔÚÅàÑø72СʱºóÔٴβⶨ¡£½á¹ûÈçÏ£º

£¨-£©Ð¡ÓÚ¼ì²âÏÞ£¬£¨+£©´ïµ½Ô¼400 pg/ml£¬(++)´óÓÚ400 pg/ml¡£±íÖÐÊý¾Ý±íÃ÷£¬ÔÚGA RSµÄ´Ì¼¤Ï£¬LNϸ°û·ÖÃÚ³öIL-2£¬INF-¦Ã£¬IL-10ºÍIL-6£¬µ«ÊÇTNF-¦Á£¬IL-4£¬IL-13£¬TGF-¦ÂÔòδ¼ì²âµ½¡£±íÃ÷GA RS ÌØÒìÐÔTϸ°û·ÖÃÚµÄϸ°ûÒò×ÓÊÇTH0Ð͵ġ£
ÓÉÓÚ·ÖÃÚµÄIL-2ÓëGA RS ¾ßÓкܺõÄÖØÏÖÐÔ¼°ÏßÐÔ¹ØÏµ£¬ËùÒÔIL-2ÊǺâÁ¿Tϸ°û¼¤»îµÄ×î¼Ñϸ°ûÒò×Ó¡£

ʵÑé2B£ºÓÅ»¯ÃâÒß¹ý³Ì
ΪÁËÓÅ»¯ÃâÒß·½°¸£¬Éè¼ÆÈçÏÂʵÑé¡£µÚÒ»¸öʵÑé²âÊÔGA RS£¨ÃâÒß¿¹Ô­£©¼ÁÁ¿¶ÔÁÜ°ÍºÍÆ¢ÔàÖеÄTϸ°û·´Ó¦µÄÓ°Ïì¡£½á¹û±íÃ÷ÁܰÍÖÐTϸ°û·ÖÃÚµÄIL-2±ÈÆ¢ÔàÖзÖÃڵĶ࣬Òò´ËÑ¡Ôñ³õ¼¶ÅàÑøµÄLNϸ°ûÓÃÓÚ²âÊÔ¡£ÁíÍ⣬ÔÚÅàÑø¹ý³ÌÖУ¬GA RSµÄ¼ÁÁ¿¶ÔTϸ°û·´Ó¦Ã»ÓÐÓ°Ïì¡£ÔÚGA RS ¼ÁÁ¿²»Í¬µÄÇé¿öÏ£¬LNºÍÆ¢Ôàϸ°û¶¼ÄÜ·ÖÃÚµÈÁ¿µÄIL-2£¬Õâ±íÃ÷ÃâÒß¹ý³ÌÊǽ¡¿µµÄ£¬¼´Ê¹GA RS¼ÁÁ¿²î±ðºÜ´óÒ²²»Ó°ÏìÃâÒß½á¹û¡£
½øÒ»²½ÓÅ»¯ÃâÒß·½°¸£¬ ʵÑé±íÃ÷ÿֻС°×Êó×¢Éä250 µg GA RS+CFA±ÈÿֻעÉä10 mgGA£«ICFA(½ÏÈõµÄ¸¨ÁÏ)ÒªºÃµÃ¶à¡£250 µg/Ö»ÄܺÜÓÐЧµÄBlock EAE(ÖÁÉÙ80£¥)
ÌØÒìÐÔTϸ°ûͨ³£ÔÚÃâÒß10Ìì×óÓҲŲúÉú£¬Òò´ËÃâÒßʱ¼äΪ9-11Ìì¡£
ʵÑé2C£ºÓÅ»¯ÌåÍâʵÑéÌõ¼þ
1¡¢ ÅàÑøÃ½½é
ʵÑéÖÐÓõ½4¸öÅàÑøÃ½½é£º1£©RPMI+1%NMS£¬2) RPMI+1%FBS£¬3£©Biotarget£¬4£©DCCM1(²»º¬Serum ý½é)£¬ÆäÖÐ×îÓŵÄΪµÚËĸö¡£
2¡¢ IL£­2µÄ·ÖÃÚ¶¯Á¦Ñ§
·ÖÃÚ¶¯Á¦Ñ§±íÃ÷ÅàÑøÊ±¼ä×î¼ÑΪ18-21h
3¡¢Ï¸°ûÒò×Ӳⶨ
IL-2ͨ¹ýOptEIA(Pharmingen, Cat.#2614KI)-a ELISA kit specific for mouse IL-2£¬ÕâÖÖELISA kit·Ç³£ÁéÃô£¬½á¹û·Ç³£¾«È·£¬²¢ÇÒÖØÏÖÐԸߡ£
4¡¢²âÊÔÑùÆ·ÖеÄIL-2ÔÚ£­20¡æÏµÄÎȶ¨ÐÔ
£­20¡æ¿É±£´æÒ»ÐÇÆÚ¡£
5¡¢GA RS ÈÜÒºÔÚ£­20¡æÏµÄÎȶ¨ÐÔ
£­20¡æ¿É±£´æ5¸öÔÂ
ʵÑé2D: ²â¶¨GA RS УÕýÇúÏßµÄÏßÐÔ·¶Î§


ʵÀý3£ºÊµÀýÒ»µÄ֤ʵ
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ glzeng µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] һ־Ըͬ¼Ã´óѧ323·Ö£¨080500£©Çóµ÷¼Á +4 yikeniu 2026-04-01 4/200 2026-04-01 14:06 by asdfzly
[¿¼ÑÐ] ¿¼Ñе÷¼Á +11 Amber00 2026-03-31 11/550 2026-04-01 11:32 by wangjy2002
[¿¼ÑÐ] 275Çóµ÷¼Á +7 waltzh 2026-04-01 7/350 2026-04-01 11:23 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] »¯Ñ§0703 µ÷¼Á 306·Ö Ò»Ö¾Ô¸211 +12 26ÒªÉϰ¶ 2026-03-28 12/600 2026-04-01 11:10 by chemdavid
[¿¼ÑÐ] 301Çóµ÷¼Á +8 axibli 2026-04-01 8/400 2026-04-01 09:51 by ÎҵĴ¬Îҵĺ£
[¿¼ÑÐ] 322Çóµ÷¼Á +4 ìäÙÒXX 2026-03-31 4/200 2026-04-01 08:21 by JourneyLucky
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +3 ÏàÐűػá¹ââÍòÕ 2026-03-31 3/150 2026-04-01 02:16 by СÇཷ26
[¿¼ÑÐ] ÕÅ·¼Ãú-Öйúũҵ´óѧ-»·¾³¹¤³Ìר˶-298 +9 ÊÖ»úÓû§ 2026-03-26 9/450 2026-03-31 18:09 by 544594351
[¿¼ÑÐ] Çóµ÷¼Á ÉúÎïѧ 377·Ö +6 zzll03 2026-03-31 6/300 2026-03-31 17:33 by ÌÆãå¶ù
[¿¼ÑÐ] 353Çóµ÷¼Á +3 ½­ÉÏ·ã_26 2026-03-28 3/150 2026-03-31 15:53 by jp9609
[¿¼ÑÐ] 085601 ²ÄÁϹ¤³Ì 313·Ö Çóµ÷¼Á +6 Ong3 2026-03-27 6/300 2026-03-31 15:18 by yanflower7133
[¿¼ÑÐ] 354Çóµ÷¼Á +3 lxb598 2026-03-31 4/200 2026-03-31 13:42 by sophie2180
[¿¼ÑÐ] 085600 295·ÖÇóµ÷¼Á +13 W55j 2026-03-30 15/750 2026-03-31 13:29 by ÍõÁÁ_´óÁ¬Ò½¿Æ´ó
[¿¼ÑÐ] 266Çóµ÷¼Á +3 ÍÛºôºßºôºß 2026-03-29 3/150 2026-03-31 10:06 by cal0306
[¿¼ÑÐ] 292Çóµ÷¼Á +13 ÊÇåû×ÓÒ²ÊÇÑÐ×Ó 2026-03-30 13/650 2026-03-30 18:01 by СÐì0109
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +3 raojunqi0129 2026-03-28 3/150 2026-03-28 15:27 by ÂäÉ˼
[¿¼ÑÐ] 0856µ÷¼Á +5 ÇóÇóÈÃÎÒÓÐÊé¶Á° 2026-03-26 6/300 2026-03-27 15:12 by caszguilin
[ÂÛÎÄͶ¸å] Journal of Mechanical Science and Technology +3 Russ_ss 2026-03-25 5/250 2026-03-27 10:49 by ½С¹û»­´ó±ý
[¿¼ÑÐ] 292Çóµ÷¼Á +4 ÇóÇóÁËÊÕÏÂÎÒ°É£ 2026-03-26 4/200 2026-03-27 10:37 by zhshch
[¿¼ÑÐ] 085602»¯Ñ§¹¤³ÌÇóµ÷¼Á¡£ +4 ƽÀÖÀÖÀÖ 2026-03-26 4/200 2026-03-26 17:57 by fmesaito
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û